DexCom, Inc.
DXCMNASDAQHealthcareMedical Devices
As of Oct 22, 2026 close
- Market cap
- $30.55B
- P/E (TTM)
- 30.56
- Forward P/E
- 17.80
- Dividend yield
- -
- 52-week range
- $54.11$92.59
- Volume (live)
- -
- Avg. volume (3M)
- 4.16M
DexCom (DXCM) Stock Price & Financial Analysis
DexCom Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $77.11 - $80.49 |
|---|---|
| 52-Week High | $92.59 |
| 52-Week Low | $54.11 |
| Open | $79.90 |
| Volume (last close) | 10.79M |
| Average Volume (3M) | 4.16M |
| Revenue (TTM) | 4.97B |
|---|---|
| Net Income (TTM) | 999.70M |
| Free Cash Flow (TTM) | 1.41B |
| EPS (TTM) | $2.52 |
| Profit Margin | 20.12% |
| Operating Margin | 22.92% |
| Return on Equity (ROE) | 38.14% |
| Debt to Equity | 0.48 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Payout Ratio | 0.00% |
| Market Cap | 30.55B |
|---|---|
| Shares Outstanding | 390.10M |
| P/E Ratio (TTM) | 30.56 |
| Forward P/E | 17.80 |
| Price to Sales (P/S) | 6.15 |
| Price to Book (P/B) | 11.66 |
| EV/EBITDA | 19.73 |
| 50-Day MA | $87.53 |
|---|---|
| 200-Day MA | $74.16 |
| 1-Year Change | +10.22% |
Source: Market prices and company fundamentals. Data as of Oct 22, 2026. Data sources and methodology
DexCom at a Glance
As of the Oct 22, 2026 close, DexCom (DXCM) has a market capitalization of $30.55B. The stock trades at 30.6× trailing earnings, 17.8× forward earnings and 6.2× sales. Over the trailing twelve months it earned $999.70M on revenue of $4.97B (a 20.1% profit margin) and generated $1.41B of free cash flow. Revenue grew 15.5% year over year.
As of its latest reported balance sheet, it holds $1.10B in cash and securities against $1.26B of debt, a net debt position of $158.50M.
DexCom does not currently pay a dividend.
The share price is up 10.2% over the past year. At $78.32 (the Oct 22, 2026 close) it sits within its 52-week range of $54.11 to $92.59, above its 200-day moving average of $74.16.
Based on 23 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $96.39, 23.1% above the Oct 22, 2026 close.
Frequently Asked Questions About DexCom
What is the current stock price for DXCM?
As of the Oct 22, 2026 close, DXCM stock trades at $78.32. The 52-week range is $54.11–$92.59, with a day range of $77.11–$80.49.
What is the P/E ratio for DXCM?
As of the Oct 22, 2026 close, DexCom's trailing twelve-month (TTM) P/E ratio is 30.6, meaning investors pay $30.6 for every $1 of annual earnings. The forward P/E is 17.8, reflecting analyst expectations for future earnings. DexCom operates in the Healthcare sector.
Does DXCM pay dividends?
DexCom does not currently pay a regular dividend. The company retains its earnings to reinvest in the business. Check the Dividends tab for historical dividend information.
What do analysts recommend for DXCM?
Based on ratings from 23 professional analysts over the last 90 days, the consensus for DXCM is Buy. The average 12-month price target is $96.39, a 23.1% upside from the Oct 22, 2026 close of $78.32.
What is the market cap of DXCM?
As of the Oct 22, 2026 close, DexCom's market capitalization is $30.55B, classifying it as a large-cap company. DexCom operates in the Healthcare sector within the Medical Devices industry.